Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Nursing Studies|April 8, 2009
Attitudes of nurses toward current and proposed vaccines for public programs: a questionnaire surveyVladimir Gilca, Nicole Boulianne, Eve Dubé, et al.
Human Vaccines & Immunotherapeutics|September 12, 2018
Canadian older adults' perceptions of effectiveness and value of regular and high-dose influenza vaccinesJennifer A Pereira, Vladimir Gilca, Nancy Waite, et al.
BMC Public Health|October 27, 2007
Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, CanadaChantal Sauvageau, Bernard Duval, Vladimir Gilca, et al.
BMC Geriatrics|June 28, 2019
EXamining the knowledge, Attitudes and experiences of Canadian seniors Towards influenza (the EXACT survey)Melissa K Andrew, Vladimir Gilca, Nancy Waite, et al.
Expert Review of Vaccines|October 4, 2017
Absence of association between Guillain-Barré syndrome hospitalizations and HPV-vaccineGeneviève Deceuninck, Chantal Sauvageau, Vladimir Gilca, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|November 14, 2018
Herpes Zoster Burden in Canadian Provinces: A Narrative Review and Comparison with Quebec Provincial DataMarie-Claude Letellier, Rachid Amini, Vladimir Gilca, et al.
The Pediatric Infectious Disease Journal|August 13, 2009
Long-term immunogenicity of two pediatric doses of combined hepatitis A and B or monovalent hepatitis B vaccine in 8 to 10-year-old children and the effect of a challenge dose given seven years laterVladimir Gilca, Marc Dionne, Nicole Boulianne, et al.
BMC Infectious Diseases|June 12, 2015
Dramatic reduction in hepatitis B through school-based immunization without a routine infant program in a low endemicity regionTeegwendé Valérie Porgo, Vladimir Gilca, Gaston De Serres, et al.
Vaccine|August 14, 2020
A systematic literature review of the recombinant subunit herpes zoster vaccine use in immunocompromised 18-49 year old patientsÉtienne Racine, Vladimir Gilca, Rachid Amini, et al.
Vaccine|October 26, 2019
The immune response to a two-dose schedule of quadrivalent HPV vaccine in 9-13 year-old girls: Is it influenced by age, menarche status or body mass index?Chantal Sauvageau, Vladimir Gilca, Robine Donken, et al.
Pageof 7